You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Tarpon Biosystems | Pall Corporation

Pall Corporation has acquired the BioSMB technology platform from Tarpon Biosystems. Click here to learn more.

BioSMB® technology outperforms traditional downstream processing by more than a factor of 5x.

We've achieved this improvement by integrating disposable, single use flow path technology into one system that is innovative by design yet easy to adopt. The result is intensified purification that increases efficiency, and maintains current chromatograhic chemistries and buffer systems while reducing cost—and it's all fully scalable from our BioSMB® Process Development System to our BioSMB® Production System. Big claims indeed. Let us share with you verifiable data from our projects with major pharmaceutical and biotechnology companies and demonstrate the power of 'continuous purification made practical' in person.